Drugs / HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN
HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN
also known as
PedvaxHIB
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01337167 | Apr 2011 → May 2013 | bacterial infectious disease, viral infectious disease | Merck Sharp & Dohme LLC | Completed | Mixed |
| Phase 41 trial · 1 met primary | ||||||
| Phase 4 | NCT00289913 | Apr 2006 → Jun 2010 | hepatitis A virus infection | Merck Sharp & Dohme LLC | Completed | Met primary |
| Comparator or background therapy6 trials | ||||||
| Phase 2 | NCT01545375 Background | May 2012 → Jul 2016 | streptococcal infection | GlaxoSmithKline | Completed | Missed primary |
| Phase 2 | NCT00134719 Comparator | Apr 2005 → Jul 2006 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01978093 Comparator | Feb 2014 → Mar 2016 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00345683 Comparator | Jul 2007 → Sep 2008 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00289783 Comparator | Feb 2006 → Aug 2007 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT04978818 Comparator | Jan 2022 → Oct 2023 | haemophilus infectious disease | Johns Hopkins Bloomberg School of Public Health | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN | ChEMBL registry synonym — accepted as the source's own label CHEMBL4298071 ↗ |
| Known as | PedvaxHIB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04978818 ↗ |
| Modality | Vaccine | “ActHIB, PedvaxHIB vaccines were administered intramuscularly in the right upper thigh and Pediarix vaccine in the left upper thigh.” NCT00289783 ↗ |
| Route | Intramuscular | “ActHIB, PedvaxHIB vaccines were administered intramuscularly in the right upper thigh and Pediarix vaccine in the left upper thigh.” NCT00289783 ↗ |